What is Blueprint AI?
Founded in 2019 by Danny Freed, Blueprint AI operates at the intersection of mental health and enterprise software. The company was established to address the systemic inefficiencies within the behavioral health sector, specifically targeting the outdated diagnostic and tracking tools that have long hindered clinical efficacy. By integrating sophisticated AI-driven workflows, Blueprint AI empowers mental health professionals to move beyond manual, fragmented processes, enabling a more streamlined and data-informed approach to patient care. The platform serves as a digital bridge between clinical intuition and measurable patient progress, effectively digitizing the therapeutic journey to ensure that practitioners can focus on what matters most: the patient experience.
How much funding has Blueprint AI raised?
Blueprint AI has raised a total of $3.4M across 1 funding round:
Angel/Seed
$3.4M
Angel/Seed (2020): $3.4M with participation from Lightbank and Bonfire Ventures
Key Investors in Blueprint AI
Lightbank
Lightbank is an investment firm based in Chicago, IL, focusing on funding innovative startups. The company aims to support entrepreneurs by providing capital and strategic guidance.
Bonfire Ventures
Bonfire Ventures is a lead investor specialized in funding ambitious B2B software startups at the seed stage, focusing on delivering responsive and personalized support.
What's next for Blueprint AI?
With this major strategic investment, Blueprint AI is well-positioned to scale its operations and expand its footprint within the enterprise healthcare market. The company's roadmap likely involves deepening its integration capabilities with existing electronic health record systems and enhancing its predictive analytics engine to provide more granular insights into patient recovery trajectories. As the firm continues to mature, the focus will shift toward broader adoption among large-scale health systems and behavioral health networks, aiming to set a new industry standard for data-driven mental health delivery. The strategic deployment of these funds will be instrumental in sustaining the company's growth trajectory and solidifying its competitive advantage in the rapidly evolving digital therapeutics landscape.
See full Blueprint AI company page